Garg V - Search Results

1

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.

Dale DC, Firkin F, Bolyard AA, Kelley M, Makaryan V, Gorelick KJ, Ebrahim T, Garg V, Tang W, Jiang H, Skerlj R, Beaussant Cohen S. Dale DC, et al. Among authors: garg v. Blood. 2020 Dec 24;136(26):2994-3003. doi: 10.1182/blood.2020007197. Blood. 2020. PMID: 32870250 Free PMC article. Clinical Trial.

2

Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapy.

Luo X, Trevejo J, van Heeswijk RP, Smith F, Garg V. Luo X, et al. Among authors: garg v. Antimicrob Agents Chemother. 2012 Jul;56(7):3641-7. doi: 10.1128/AAC.00077-12. Epub 2012 May 7. Antimicrob Agents Chemother. 2012. PMID: 22564847 Free PMC article. Clinical Trial.

3

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.

Garg V, van Heeswijk R, Lee JE, Alves K, Nadkarni P, Luo X. Garg V, et al. Hepatology. 2011 Jul;54(1):20-7. doi: 10.1002/hep.24443. Hepatology. 2011. PMID: 21618566 Clinical Trial.

4

Telaprevir: pharmacokinetics and drug interactions.

Garg V, Kauffman RS, Beaumont M, van Heeswijk RP. Garg V, et al. Antivir Ther. 2012;17(7):1211-21. doi: 10.3851/IMP2356. Epub 2012 Sep 7. Antivir Ther. 2012. PMID: 22954756 Review.

5

Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin.

Lee JE, van Heeswijk R, Alves K, Smith F, Garg V. Lee JE, et al. Among authors: garg v. Antimicrob Agents Chemother. 2011 Oct;55(10):4569-74. doi: 10.1128/AAC.00653-11. Epub 2011 Aug 8. Antimicrob Agents Chemother. 2011. PMID: 21825288 Free PMC article. Clinical Trial.

6

Effect of telaprevir on the pharmacokinetics of midazolam and digoxin.

Garg V, Chandorkar G, Farmer HF, Smith F, Alves K, van Heeswijk RP. Garg V, et al. J Clin Pharmacol. 2012 Oct;52(10):1566-73. doi: 10.1177/0091270011419850. Epub 2011 Dec 12. J Clin Pharmacol. 2012. PMID: 22162542 Clinical Trial.

7

The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers.

Garg V, Chandorkar G, Yang Y, Adda N, McNair L, Alves K, Smith F, van Heeswijk RP. Garg V, et al. Br J Clin Pharmacol. 2013 Feb;75(2):431-9. doi: 10.1111/j.1365-2125.2012.04345.x. Br J Clin Pharmacol. 2013. PMID: 22642697 Free PMC article.

8

Pharmacokinetic interaction between telaprevir and methadone.

van Heeswijk R, Verboven P, Vandevoorde A, Vinck P, Snoeys J, Boogaerts G, De Paepe E, Van Solingen-Ristea R, Witek J, Garg V. van Heeswijk R, et al. Among authors: garg v. Antimicrob Agents Chemother. 2013 May;57(5):2304-9. doi: 10.1128/AAC.02262-12. Epub 2013 Mar 11. Antimicrob Agents Chemother. 2013. PMID: 23478952 Free PMC article. Clinical Trial.

9

Review of drug interactions with telaprevir and antiretrovirals.

van Heeswijk RP, Beumont M, Kauffman RS, Garg V. van Heeswijk RP, et al. Among authors: garg v. Antivir Ther. 2013;18(4):553-60. doi: 10.3851/IMP2527. Epub 2013 Jan 23. Antivir Ther. 2013. PMID: 23344266 Review.

10

Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies.

Haseltine EL, Kimko H, Luo H, Tolsma J, Bartels DJ, Kieffer TL, Garg V. Haseltine EL, et al. Among authors: garg v. J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):681-98. doi: 10.1007/s10928-015-9435-z. Epub 2015 Aug 20. J Pharmacokinet Pharmacodyn. 2015. PMID: 26289844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,069 results

Search Page

Filters